Abstract
We describe a case of percutaneous tricuspid valve implantation in a 20-year-old man with previous tricuspid valve replacement in the setting of pulmonary atresia with intact ventricular septum. He developed symptomatic endocarditis-induced tricuspid regurgitation of the tricuspid bioprosthesis. Tricuspid valvar competence was restored with implantation of a 26-mm Edwards SAPIEN valve.
Copyright © 2011 Wiley-Liss, Inc.
MeSH terms
-
Bioprosthesis / adverse effects*
-
Cardiac Catheterization / instrumentation*
-
Endocarditis, Bacterial / microbiology
-
Endocarditis, Bacterial / therapy*
-
Heart Valve Prosthesis / adverse effects*
-
Heart Valve Prosthesis Implantation / adverse effects*
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Humans
-
Male
-
Prosthesis Design
-
Prosthesis-Related Infections / microbiology
-
Prosthesis-Related Infections / therapy*
-
Treatment Outcome
-
Tricuspid Valve / surgery*
-
Young Adult